Physiomics (LON:PYC) Stock Price Down 2.8% – Here’s Why

Shares of Physiomics Plc (LON:PYC) were down 2.8% during trading on Wednesday . The stock traded as low as GBX 0.33 and last traded at GBX 0.39. Approximately 42,169,820 shares were traded during trading, an increase of 464% from the average daily volume of 7,479,108 shares. The stock had previously closed at GBX 0.40.

Physiomics Stock Performance

The firm’s 50 day moving average price is GBX 0.42 and its two-hundred day moving average price is GBX 0.40. The company has a market cap of £1.52 million, a P/E ratio of -3.33 and a beta of 1.01.

Physiomics (LON:PYC) last issued its earnings results on Monday, February 16th. The company reported GBX (0.10) earnings per share (EPS) for the quarter. Physiomics had a negative return on equity of 89.43% and a negative net margin of 50.92%. As a group, analysts forecast that Physiomics Plc will post -0.13 EPS for the current fiscal year.

Physiomics Company Profile

Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. It also develops technology for use in the field of personalized medicine. The company was incorporated in 2001 and is based in Oxford, the United Kingdom.